Hansen, B. E. Et Al. 2022. MARALIXIBAT-TREATED PATIENTS WITH ALAGILLE SYNDROME DEMONSTRATE IMPROVED EVENT-FREE SURVIVAL IN A NATURAL HISTORY COMPARISON WITH PATIENTS FROM THE GALA DATABASE: APPLICATION OF REAL-WORLD EVIDENCE ANALYTICS. . NASPGHAN 2022 Annual Meeting , 211-213.

Hansen, B. E., Vandriel, S. M., Vig, P., Garner, W., Loomes, K. M., Piccoli, D. A., ... Rand, L. B.(2022). MARALIXIBAT-TREATED PATIENTS WITH ALAGILLE SYNDROME DEMONSTRATE IMPROVED EVENT-FREE SURVIVAL IN A NATURAL HISTORY COMPARISON WITH PATIENTS FROM THE GALA DATABASE: APPLICATION OF REAL-WORLD EVIDENCE ANALYTICS. . NASPGHAN 2022 Annual Meeting (pp.211-213).

Hansen, Betina Et Al. "MARALIXIBAT-TREATED PATIENTS WITH ALAGILLE SYNDROME DEMONSTRATE IMPROVED EVENT-FREE SURVIVAL IN A NATURAL HISTORY COMPARISON WITH PATIENTS FROM THE GALA DATABASE: APPLICATION OF REAL-WORLD EVIDENCE ANALYTICS. ," NASPGHAN 2022 Annual Meeting, 2022

Hansen, Betina E. Et Al. "MARALIXIBAT-TREATED PATIENTS WITH ALAGILLE SYNDROME DEMONSTRATE IMPROVED EVENT-FREE SURVIVAL IN A NATURAL HISTORY COMPARISON WITH PATIENTS FROM THE GALA DATABASE: APPLICATION OF REAL-WORLD EVIDENCE ANALYTICS. ." NASPGHAN 2022 Annual Meeting , pp.211-213, 2022

Hansen, B. E. Et Al. (2022) . "MARALIXIBAT-TREATED PATIENTS WITH ALAGILLE SYNDROME DEMONSTRATE IMPROVED EVENT-FREE SURVIVAL IN A NATURAL HISTORY COMPARISON WITH PATIENTS FROM THE GALA DATABASE: APPLICATION OF REAL-WORLD EVIDENCE ANALYTICS. ." NASPGHAN 2022 Annual Meeting , pp.211-213.

@conferencepaper{conferencepaper, author={Betina E. Hansen Et Al. }, title={MARALIXIBAT-TREATED PATIENTS WITH ALAGILLE SYNDROME DEMONSTRATE IMPROVED EVENT-FREE SURVIVAL IN A NATURAL HISTORY COMPARISON WITH PATIENTS FROM THE GALA DATABASE: APPLICATION OF REAL-WORLD EVIDENCE ANALYTICS. }, congress name={NASPGHAN 2022 Annual Meeting}, city={}, country={}, year={2022}, pages={211-213} }